logo_sofi Purpose People Portfolio Platforms Press Press FILTER BY: ALL EVENTS SOFINNOVA NEWS PORTFOLIO NEWS PORTFOLIO NEWS Nov 16, 2021 NorthSea Announces Icosabutate Latest Phase 2b Interim Data Show Significant Decreases in NASH and Fibrosis Biomarkers Independent of Fibrosis Stage and Disease Severity PORTFOLIO NEWS Nov 08, 2021 Gyroscope Therapeutics Announces Sanofi Investment of up to $60 Million PORTFOLIO NEWS Nov 02, 2021 Antiva Biosciences Closes $31 Million Series D Equity Financing PORTFOLIO NEWS Oct 26, 2021 Quanta Therapeutics Announces Oversubscribed $60 Million Series C Financing to Advance Novel RAS-targeting Programs PORTFOLIO NEWS Oct 12, 2021 CinCor Pharma Raises $143 Million in Series B Financing PORTFOLIO NEWS Oct 07, 2021 NextCure Announces Publication of Preclinical Data for NC410 PORTFOLIO NEWS Oct 04, 2021 Inozyme Pharma Announces Presentation of Data from ENPP1 Deficiency Development Program EVENT Sep 30, 2021 Sarah Bhagat will join Making Smart Investments panel during Longwood Healthcare Leaders Meeting on October 4 at 5:10pm ET PORTFOLIO NEWS Sep 30, 2021 Gyroscope Therapeutics Announces Presentation of Positive Interim Phase I/II Data for Investigational Gene Therapy GT005 PORTFOLIO NEWS Sep 29, 2021 NuCana Receives Fast Track Designation from the U.S. Food and Drug Administration for Acelarin® (NUC-1031) for the Treatment of Biliary Tract Cancer EVENT Sep 23, 2021 Maha Katabi to join panel during Johnson & Johnson webinar on Battling Chronic Kidney Disease (CKD) on Tuesday, September 28 at 10:30am PT. PORTFOLIO NEWS Sep 13, 2021 Y-mAbs Announces Priority Review of BLA for DANYELZA® (naxitamab-gqgk) in China PORTFOLIO NEWS Sep 08, 2021 Bolt Announces Clinical Collaboration with Bristol Myers Squibb to Study BDC-1001 in Combination with Opdivo® PORTFOLIO NEWS Aug 25, 2021 Ascendis Announces U.S. Food and Drug Administration Approval of SKYTROFA®, the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency PORTFOLIO NEWS Aug 11, 2021 Akouos Announces European Commission Designation of AK-OTOF for the Treatment of Otoferlin Gene-Mediated Hearing Loss as an Orphan Drug PORTFOLIO NEWS Jul 27, 2021 XyloCor Therapeutics Commences Phase 2 Component of Phase 1/2 EXACT Clinical Study of XC001 Gene Therapy for Refractory Angina PORTFOLIO NEWS Jul 27, 2021 ObsEva and Organon Enter Global License Agreement to Develop and Commercialize Ebopiprant (OBE022), an Investigational Agent Being Evaluated as a First-in-Class Treatment for Preterm Labor PORTFOLIO NEWS Jul 07, 2021 Neurana Pharmaceuticals Announces Publication in Pain Management PORTFOLIO NEWS Jul 06, 2021 Athira Pharma Announces Initiation of Open Label Extension Study for LIFT-AD and ACT-AD Clinical Trials of ATH-1017 for Alzheimer’s Disease PORTFOLIO NEWS Jul 06, 2021 Y-mAbs Announces NMPA Submission of BLA for DANYELZA® (naxitamab-gqgk) in China PORTFOLIO NEWS Jul 06, 2021 Ascendis Announces Target Enrollment Achieved in the Phase 3 PaTHway Trial of TransCon™ PTH (palopegteriparatide) in Adults with Hypoparathyroidism (HP) PORTFOLIO NEWS Jun 29, 2021 Aerovate Therapeutics Announces Pricing of Upsized Initial Public Offering PORTFOLIO NEWS Jun 25, 2021 Y-mAbs’ 177Lu-omburtamab-DTPA for the Treatment of Patients with Medulloblastoma Receives Positive Opinion on Orphan Medicinal Product Designation by EMA PORTFOLIO NEWS Jun 24, 2021 Natera and BGI Genomics Announce Commercial Launch of the BGI/Natera Signatera Assay in China PORTFOLIO NEWS Jun 23, 2021 Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers PORTFOLIO NEWS Jun 22, 2021 Gyroscope Therapeutics Announces Research Collaboration Agreement with Children’s Medical Research Institute to Develop Novel Gene Therapy Capsids PORTFOLIO NEWS Jun 22, 2021 Pionyr and Abcam Extend Partnership to Evaluate TREM2-Expressing Cells in Cancer Patients EVENT Jun 11, 2021 Sarah Bhagat to join Panel Discussion on Neurological Disorder Therapeutics at Biotech by the Lake Summit on Tuesday, June 22 at 10:25am CST PORTFOLIO NEWS Jun 09, 2021 Inozyme Announces Acceptance of First European Clinical Trial Application for Phase 1/2 Clinical Trial of INZ-701 in ABCC6 Deficiency PORTFOLIO NEWS Jun 07, 2021 Neurana Pharmaceuticals Announces 50% Enrollment in Phase 3, RESUME-1 Study PORTFOLIO NEWS Jun 04, 2021 VISEN Pharmaceuticals obtained IND approval for phase III China clinical trial (PaTHway China Trial) of TransCon PTH Solution for Injection (TransCon™ parathyroid hormone) PORTFOLIO NEWS Jun 02, 2021 Bolt Biotherapeutics and Genmab Announce Oncology Research and Development Collaboration PORTFOLIO NEWS May 14, 2021 Apellis Announces FDA Approval of EMPAVELI™ (pegcetacoplan) for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH) PORTFOLIO NEWS May 13, 2021 Vera Therapeutics Announces Pricing of Initial Public Offering PORTFOLIO NEWS May 04, 2021 Kiniksa Announces Positive Final Data from Phase 1 Trial of KPL-404 PORTFOLIO NEWS Apr 29, 2021 Inozyme Pharma Publishes Data Supporting INZ-701 as a Potential Treatment for ENPP1 Deficiency PORTFOLIO NEWS Apr 28, 2021 Pfizer Acquires Amplyx Pharmaceuticals PORTFOLIO NEWS Apr 28, 2021 Galera Announces Updated Data from its Randomized, Multicenter, Placebo-Controlled Trial in Patients with Pancreatic Cancer PORTFOLIO NEWS Apr 27, 2021 Y-mAbs Submits Omburtamab Marketing Authorization Application to the European Medicines Agency EVENT Apr 23, 2021 Sarah Bhagat to join Investor Roundtable at the Virtual Neuroscience Innovation Forum (NIF) hosted by Sachs Associates on April 28 at 2:40pm ET PORTFOLIO NEWS Apr 20, 2021 Y-mAbs Provides Regulatory Update on Omburtamab PORTFOLIO NEWS Apr 19, 2021 Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Phase 2 Head and Neck Cancer Trial PORTFOLIO NEWS Apr 16, 2021 Gyroscope Therapeutics Files Registration Statement for Proposed Initial Public Offering in the United States PORTFOLIO NEWS Apr 13, 2021 Akouos Receives Orphan Drug and Rare Pediatric Disease Designations for AK-OTOF for the Treatment of Otoferlin Gene-Mediated Hearing Loss PORTFOLIO NEWS Apr 01, 2021 Kiniksa Announces Commercial Availability of ARCALYST ® (rilonacept) for Recurrent Pericarditis PORTFOLIO NEWS Mar 31, 2021 Natera and Tesis Labs Announce Strategic Collaboration on Prenatal Genetic Testing PORTFOLIO NEWS Mar 30, 2021 Amarin Receives European Commission (Ec) Approval for Vazkepa to Reduce Cardiovascular Risk PORTFOLIO NEWS Mar 30, 2021 VISEN’s TransConTM Human Growth Hormone Phase-III Clinical Trial in China Completes Target Patient Recruitment Number as Schedule PORTFOLIO NEWS Mar 29, 2021 Pionyr Immunotherapeutics Collaborates with Lonza to Support their Oncology Product Development PORTFOLIO NEWS Mar 26, 2021 Gyroscope Therapeutics Announces $148 Million Raised in Series C Financing PORTFOLIO NEWS Mar 22, 2021 XyloCor Therapeutics Completes Oversubscribed $41.9 Million Series A Financing To Advance Novel Gene Therapy Pipeline For Coronary Artery Disease PORTFOLIO NEWS Mar 18, 2021 Kiniksa Announces FDA Approval of ARCALYST ® (rilonacept) for Recurrent Pericarditis PORTFOLIO NEWS Mar 12, 2021 The Balancing Act® on Lifetime to Feature ENPP1 Deficiency SOFINNOVA NEWS Feb 22, 2021 Jim Healy Receives 2021 NVCA "Excellence in Healthcare Innovation" Award for his Commitment to Improving the Lives of Patients Through Science PORTFOLIO NEWS Feb 17, 2021 Coherus BLA Filing for Adalimumab Biosimilar Candidate Accepted by FDA for Review PORTFOLIO NEWS Feb 10, 2021 ObsEva Provides Business Outlook for 2021 PORTFOLIO NEWS Feb 04, 2021 Bolt Biotherapeutics Prices Upsized Initial Public Offering PORTFOLIO NEWS Jan 21, 2021 Athira Pharma Announces Pricing of Public Offering of Common Stock PORTFOLIO NEWS Jan 19, 2021 Vera Therapeutics Launches with $80 Million Series C Financing to Develop Phase 2b Novel Biologic for Kidney Disease SOFINNOVA NEWS Jan 12, 2021 Sofinnova's Chief Legal Officer Hooman Shahlavi featured in Vanguard Law Magazine PORTFOLIO NEWS Jan 11, 2021 Akouos and Blueprint Genetics Announce the Resonate Program to Improve Access to Genetic Testing for Individuals with Auditory Neuropathy PORTFOLIO NEWS Jan 09, 2021 VISEN Closes $150 Million Series B Financing to Accelerate the Development & Commercialization of its Innovative Endocrinology Therapies in Greater China PORTFOLIO NEWS Jan 08, 2021 Positive Phase 2b ICONA interim Results for Icosabutate in NASH Patients PORTFOLIO NEWS Jan 07, 2021 Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers PORTFOLIO NEWS Jan 04, 2021 Inozyme Pharma Announces Authorization to Proceed in U.S. and U.K. with Phase 1/2 Clinical Trial of INZ-701 for the Treatment of ENPP1 Deficiency PORTFOLIO NEWS Dec 30, 2020 Ascendis Pharma A/S Announces Filing of Investigational New Drug Application to Initiate TransCon™ TLR7/8 Agonist Clinical Program SOFINNOVA NEWS Dec 21, 2020 Sarah Bhagat featured in BioWorld: Gene Therapy Surges as Risks Reduced PORTFOLIO NEWS Dec 21, 2020 Neurana Pharmaceuticals Announces First Patient Enrolled in Phase 3, RESUME-1 Study PORTFOLIO NEWS Dec 18, 2020 Y-mAbs Signs License Agreement with SciClone for DANYELZA® (naxitamab-gqgk) and Omburtamab in China PORTFOLIO NEWS Dec 18, 2020 Y-mAbs Signs Distribution Agreement with Swixx for DANYELZA® (naxitamab-gqgk) and Omburtamab in Eastern Europe PORTFOLIO NEWS Dec 17, 2020 Merus and Sema4 Enter Into an Agreement to Support Merus’ Phase 1/2 Clinical Trial of Zenocutuzumab PORTFOLIO NEWS Dec 16, 2020 Atsena Therapeutics Raises $55 Million Series A Financing to Advance LCA1 Gene Therapy Clinical Program PORTFOLIO NEWS Dec 10, 2020 ObsEva Announces Additional Phase 3 PRIMROSE 1 and 2 Study Results Confirming Sustained Efficacy and Continued Safety of linzagolix in the Treatment of Uterine Fibroids PORTFOLIO NEWS Dec 08, 2020 Checkmate Pharmaceuticals Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate CMP-001 in Combination with Nivolumab PORTFOLIO NEWS Dec 08, 2020 Athira Pharma Awarded $15 Million Grant from National Institute on Aging to Support ACT-AD Clinical Trial in Alzheimer’s Disease PORTFOLIO NEWS Dec 08, 2020 Neurana Pharmaceuticals Announces Top-Line Results from Tolperisone Phase 1 CNS Effects Study SOFINNOVA NEWS Dec 08, 2020 Sarah Bhagat Selected as One of Ten Winners for Biocom’s 2020 Life Science Catalyst Award PORTFOLIO NEWS Dec 03, 2020 Natera Announced Second Largest Commercial Insurer Covers Non-Invasive Prenatal Testing for All Pregnancies EVENT Dec 01, 2020 Maha Katabi to join panel: The Future of Biotech Financing: Continued Boom or Bust? on December 3rd at 1pm ET PORTFOLIO NEWS Dec 01, 2020 Athira Pharma Announces Initiation of Patient Dosing for Treatment of Mild-to-Moderate Alzheimer’s Disease PORTFOLIO NEWS Nov 25, 2020 FDA Approves Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the Treatment of Neuroblastoma PORTFOLIO NEWS Nov 23, 2020 Neurana Pharmaceuticals Announces Publication in the Journal of Pain Research PORTFOLIO NEWS Nov 19, 2020 Amarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of Vascepa® (Icosapent Ethyl) in Mainland China PORTFOLIO NEWS Nov 18, 2020 Chiasma Announces Positive Topline Results from the MPOWERED™ Phase 3 Clinical Trial PORTFOLIO NEWS Nov 18, 2020 Pionyr Immunotherapeutics Initiates Phase 1 Clinical Study of PY314 PORTFOLIO NEWS Nov 16, 2020 Kiniksa Announces Breakthrough Therapy Designation Granted to Vixarelimab for the Treatment of Pruritus Associated with Prurigo Nodularis PORTFOLIO NEWS Nov 16, 2020 ObsEva SA Reports Positive Topline Results of the PROLONG Proof-of-Concept Trial of Ebopiprant (OBE022) for Treatment of Preterm Labor PORTFOLIO NEWS Nov 05, 2020 Merck to Acquire VelosBio PORTFOLIO NEWS Oct 23, 2020 Ascendis Pharma A/S Receives Orphan Designation for TransCon™ PTH for Treatment of Hypoparathyroidism in Europe PORTFOLIO NEWS Oct 19, 2020 VelosBio Announces First Patient Dosed in Phase 2 Trial of VLS-101 in Solid Tumors PORTFOLIO NEWS Oct 07, 2020 Y-mAbs’ Nivatrotamab for the Treatment of Patients with Neuroblastoma Granted Orphan Drug Designation & Rare Pediatric Disease Designation by FDA PORTFOLIO NEWS Oct 06, 2020 Kiniksa Announces Positive Data from Phase 2 Trial of Mavrilimumab in Giant Cell Arteritis PORTFOLIO NEWS Sep 28, 2020 Sanofi Completes Principia Biopharma Inc. Acquisition PORTFOLIO NEWS Sep 17, 2020 Athira Pharma Announces Pricing of Initial Public Offering PORTFOLIO NEWS Sep 17, 2020 Principia Announces First Patient Dosed in Phase 2A Trial of Rilzabrutinib in IgG4-Related Disease PORTFOLIO NEWS Sep 16, 2020 Galera Therapeutics Announces Dosing of First Patient in a Randomized, Double-Blind Pilot Phase 2 Clinical Trial of GC4419 for COVID-19 PORTFOLIO NEWS Sep 15, 2020 Kiniksa Announces U.S. Orphan Drug Designation for Mavrilimumab for the Treatment of Giant Cell Arteritis PORTFOLIO NEWS Sep 14, 2020 Natera Launches Initiative to Transform the Management of Cancer Patients in Organ Transplantation PORTFOLIO NEWS Sep 08, 2020 Ascendis Pharma Submits Marketing Authorisation Application to the European Medicines Agency for TransCon™ hGH PORTFOLIO NEWS Aug 17, 2020 Sanofi to Acquire Principia Biopharma PORTFOLIO NEWS Aug 12, 2020 Ascendis Pharma Receives Orphan Designation for TransCon™ CNP for the Treatment of Achondroplasia in Europe PORTFOLIO NEWS Aug 06, 2020 Aerovate Therapeutics Emerges With $72.6 Million Funding for Potential Disease-Modifying Pulmonary Arterial Hypertension Therapy PORTFOLIO NEWS Jul 30, 2020 Inozyme Pharma Announces Closing of Initial Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares PORTFOLIO NEWS Jul 28, 2020 Karuna Therapeutics and PsychoGenics Announce Drug Discovery Collaboration PORTFOLIO NEWS Jul 27, 2020 Merus announces FDA Orphan Drug Designation of Zenocutuzumab for the Treatment of Pancreatic Cancer PORTFOLIO NEWS Jul 27, 2020 Chiasma Announces 48-Week Safety and Efficacy Data from the Open-Label Extension Study of its CHIASMA OPTIMAL Phase 3 Trial Evaluating MYCAPSSA® PORTFOLIO NEWS Jul 27, 2020 Checkmate Granted FDA Fast Track Designation for CMP-001 Combined with PD-1 Blockade PORTFOLIO NEWS Jul 23, 2020 Inozyme Pharma Announces Pricing of Initial Public Offering PORTFOLIO NEWS Jul 21, 2020 Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Upsized Public Offering PORTFOLIO NEWS Jul 20, 2020 Amplyx Announces Positive Top-Line Data in Phase 2 Clinical Trial Of Novel Antifungal Fosmanogepix PORTFOLIO NEWS Jul 20, 2020 Checkmate Pharmaceuticals Executes a Snappy 1-2 Biotech Gambit — Big Crossover Followed by an Instant IPO PORTFOLIO NEWS Jul 17, 2020 Inozyme Pharma Acquires ENPP1 Deficiency Program Assets from Alexion Pharmaceuticals PORTFOLIO NEWS Jul 16, 2020 Kiniksa Announces U.S. Orphan Drug Designation for Rilonacept for the Treatment of Pericarditis PORTFOLIO NEWS Jul 14, 2020 Natera Recognized as a 'Force for Change' by Leading Women Entrepreneurs (LWE) PORTFOLIO NEWS Jul 08, 2020 VelosBio Raises $137 Million in Series B Financing to Advance Development of ROR1-Directed Therapeutics in Oncology PORTFOLIO NEWS Jul 07, 2020 NextCure Initiates Phase 1/2 Clinical Study of NC410, a Novel Immunomedicine, for Solid Tumors PORTFOLIO NEWS Jul 06, 2020 ObsEva Announces Positive Results from two Phase 3 Studies, PRIMROSE 1 and 2, of Yselty® (linzagolix) for the Treatment of Uterine Fibroids PORTFOLIO NEWS Jul 06, 2020 Ascendis Pharma A/S Receives Positive Opinion from the Paediatric Committee of the European Medicines Agency on the Agreement of a Paediatric Investigation Plan PORTFOLIO NEWS Jun 30, 2020 Y-mAbs Announces Initiation of Submission of Omburtamab Rolling Biologics License Application to the FDA PORTFOLIO NEWS Jun 29, 2020 Kiniksa Announces Positive Data from Phase 3 Trial of Rilonacept in Recurrent Pericarditis (RHAPSODY PORTFOLIO NEWS Jun 26, 2020 Chiasma Announces FDA Approval of MYCAPSSA® (Octreotide) Capsules, the First and Only Oral Somatostatin Analog PORTFOLIO NEWS Jun 26, 2020 Ascendis Pharma A/S Announces Submission of Biologics License Application (BLA) to FDA for TransCon™ hGH in Pediatric Growth Hormone Deficiency PORTFOLIO NEWS Jun 25, 2020 Akouos Announces Pricing of Initial Public Offering PORTFOLIO NEWS Jun 23, 2020 Karuna Therapeutics Announces Positive End-of-Phase 2 Meeting with the FDA for KarXT for the Treatment of Acute Psychosis in Patients with Schizophrenia PORTFOLIO NEWS Jun 23, 2020 Gilead Sciences Secures Exclusive Option to Acquire Pionyr Immunotherapeutics PORTFOLIO NEWS Jun 15, 2020 Vascepa® Shows Significant Cardiovascular Risk Reduction in People with Diabetes in Prespecified & Post Hoc Subgroup Analyses PORTFOLIO NEWS Jun 12, 2020 Principia Announces Positive Data from its Phase 2 Part B Trial in Pemphigus PORTFOLIO NEWS Jun 10, 2020 Checkmate Pharmaceuticals Secures $85 Million in Series C Financing PORTFOLIO NEWS Jun 04, 2020 Athira Pharma Closes $85 Million Series B Financing PORTFOLIO NEWS May 14, 2020 Inozyme Pharma & GACI Global Initiate Patient Study to Improve Understanding of the Impact of Disease in Patients with ENPP1 Deficiency & ABCC6 Deficiency PORTFOLIO NEWS May 14, 2020 Vascepa® Shows Significant Reduction in Coronary Revascularization in Prespecified Tertiary Endpoint Analyses PORTFOLIO NEWS May 13, 2020 Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Public Offering PORTFOLIO NEWS May 13, 2020 Galera Therapeutics Announces New Data from the Phase 2b Trial on the Effect of Avasopasem Manganese on Cisplatin-Induced Chronic Kidney Disease EVENT Apr 24, 2020 Maha Katabi to join Biotech by the Lake Investor Summit Panel: "Financing and Investing in Oncology Biotech" PORTFOLIO NEWS Apr 22, 2020 AFYX Therapeutics Achieves Primary Endpoint in Phase 2b Trial of Rivelin-CLO in Patients with Oral Lichen Planus PORTFOLIO NEWS Apr 22, 2020 Kiniksa Announces Phase 2 Clinical Trial of Vixarelimab (KPL-716) in Prurigo Nodularis Meets Primary Efficacy Endpoint PORTFOLIO NEWS Apr 19, 2020 Ascendis Pharma A/S Announces Top-line Data from Fixed Dose Portion of Phase 2 Trial PORTFOLIO NEWS Apr 16, 2020 Natera Prices $250 Million Convertible Senior Notes Due 2027 PORTFOLIO NEWS Apr 15, 2020 Ascendis Pharma A/S Receives Orphan Drug Designation for TransCon™ hGH as Treatment for Growth Hormone Deficiency in the United States PORTFOLIO NEWS Apr 15, 2020 Coherus BioSciences Prices $200.0 Million Convertible Senior Subordinated Notes Offering PORTFOLIO NEWS Apr 01, 2020 Y-mAbs Announces Submission of Naxitamab Biologics License Application to U.S. FDA SOFINNOVA NEWS Mar 31, 2020 Sofinnova Investments Strengthens Executive Team with the Promotions of Maha Katabi, PhD, CFA and Sarah Bhagat, PhD SOFINNOVA NEWS Mar 17, 2020 Sofinnova Investments Announces the Addition of Jonathan Leff, M.D. as Executive Partner PORTFOLIO NEWS Mar 03, 2020 Akouos Closes $105 Million Series B Financing PORTFOLIO NEWS Feb 26, 2020 Y-mAbs Announces Positive Pre-BLA Meeting with FDA for Omburtamab PORTFOLIO NEWS Feb 14, 2020 Promedior Announces Completion of Acquisition by Roche EVENT Feb 07, 2020 Maha Katabi to Present at the "Meet with Series" hosted by Johnson & Johnson Innovation, JLABS EVENT Feb 05, 2020 Jason Pitts to Moderate Bio CEO and & Investor Conference Panel: "Neuroscience at the Crossroads: Late Stage Brain Disorder Pipelines and Unmet Needs" EVENT Jan 20, 2020 Jim Healy to join SuperReturn 2020 Panel: "Keeping Things Private or Going Public - Considering the Exit" PORTFOLIO NEWS Jan 15, 2020 Astellas Completes Acquisition of Audentes Therapeutics PORTFOLIO NEWS Jan 13, 2020 Chiasma Announces FDA Acceptance Of MYCAPSSA® New Drug Application Resubmission PORTFOLIO NEWS Jan 08, 2020 NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA study in NASH EVENT Dec 17, 2019 Maha Katabi to join Biotech Showcase 2020 Panel "Rare and Orphan Diseases: The Value Proposition of New Modalities vs Established Ones" PORTFOLIO NEWS Dec 02, 2019 Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutic PORTFOLIO NEWS Nov 20, 2019 Karuna Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock PORTFOLIO NEWS Nov 18, 2019 Karuna Therapeutics Announces KarXT Met Primary Endpoint in Phase 2 Clinical Trial of Acute Psychosis in Patients with Schizophrenia PORTFOLIO NEWS Nov 18, 2019 Promedior Enters Into Definitive Merger Agreement To Be Acquired By Roche PORTFOLIO NEWS Oct 25, 2019 Spark Therapeutics Wins Prix Galien USA Award for LUXTURNA® (voretigene neparvovec-rzyl) as Best Biotechnology Product PORTFOLIO NEWS Oct 21, 2019 Ascendis Pharma A/S Receives Orphan Designation for TransCon™ hGH for the Treatment of Pediatric Growth Hormone Deficiency in Europe PORTFOLIO NEWS Oct 03, 2019 Aeovian Pharmaceuticals Raises $37 Million Series A Financing to Advance Selective mTORC1 Inhibitors into the Clinic for Rare and Age-Related Diseases EVENT Oct 01, 2019 Jim Healy to join BIO Investor Forum Panel "Market Outlook—Taking the Temperature of the IPO Market in an Era of Large Pharma M&A" PORTFOLIO NEWS Sep 26, 2019 Marinus Pharmaceuticals Announces Positive Top-Line Results With Ganaxolone in Phase 2 Refractory Status Epilepticus Trial PORTFOLIO NEWS Sep 23, 2019 Neurana Pharmaceuticals Announces Positive Topline Results from Phase 2 STAR Study of Tolperisone in Acute Muscle Spasms of the Back PORTFOLIO NEWS Sep 12, 2019 Akouos Discloses Lead Program, AK-OTOF, a Potential Gene Therapy for Sensorineural Hearing Loss PORTFOLIO NEWS Sep 09, 2019 Natera Publishes Largest NIPT Outcomes Study Demonstrating Robust Clinical Performance Over a 4-year Period PORTFOLIO NEWS Aug 07, 2019 ObsEva SA Announces $75 Million Credit Facility with Oxford Finance LLC PORTFOLIO NEWS Aug 05, 2019 Natera Publication Demonstrates Unique Ability of Panorama Test to Determine Zygosity in Twin Pregnancies PORTFOLIO NEWS Aug 05, 2019 Alimera Announces ILUVIEN® Regulatory Approval in Australia for the Treatment of Diabetic Macular Edema PORTFOLIO NEWS Jul 23, 2019 Chiasma Announces Positive Phase 3 Top-Line Results From CHIASMA OPTIMAL Clinical Trial Of Mycapssa® PORTFOLIO NEWS Jul 15, 2019 Synlogic Reports Positive Top-line Data from Phase 1/2a Study of SYNB1618 in Patients with Phenylketonuria PORTFOLIO NEWS Jul 08, 2019 ObsEva SA Announces Completion of Patient Recruitment in PRIMROSE 1 PORTFOLIO NEWS Jun 27, 2019 Karuna Therapeutics Announces Pricing of Upsized Initial Public Offering SOFINNOVA NEWS May 31, 2019 Swinging for the Fences: The Dichotomy in Rare Disease Investment and Development PORTFOLIO NEWS May 14, 2019 CinCor Pharma Closes $50 Million Series A SOFINNOVA NEWS Apr 22, 2019 Sofinnova Investments Announces the Addition of Industry Veteran Maha Katabi, PhD. as a Partner PORTFOLIO NEWS Apr 10, 2019 Inozyme Pharma Raises $67 Million in Series A2 Financing PORTFOLIO NEWS Mar 28, 2019 Amarin shares new updates to the American Diabetes Association 2019 Standards of Medical Care in Diabetes PORTFOLIO NEWS Mar 19, 2019 Iterum Therapeutics Receives QIDP for Oral and IV Sulopenem in Four Additional Indications as well as Fast Track Designation PORTFOLIO NEWS Mar 04, 2019 Ascendis Pharma Announces Once-weekly TransCon™ Growth Hormone Demonstrated Superiority on Primary Endpoint PORTFOLIO NEWS Feb 25, 2019 Spark Therapeutics Enters into Definitive Merger Agreement with Roche EVENT Feb 04, 2019 Jim Healy to join Bio CEO & Investor Panel "Are Record Levels of IPOs Still Disrupting M&A Deals?" PORTFOLIO NEWS Jan 31, 2019 Kiniksa Pharmaceuticals Announces Pricing of Public Offering SOFINNOVA NEWS Jan 25, 2019 A Top VC At a $2B Fund That Invests in Risky Biotechs Reveals How He Finds His Best Investments EVENT Dec 13, 2018 Mike Powell joins AACR Panel "Entrepreneurship in Translational Research" EVENT Dec 12, 2018 Jim Healy to join East | West CEO Panel "VC Perspectives: Currant Financing Trends in Biotech" EVENT Dec 12, 2018 Jim Healy to join Biotech Showcase Panel "Rare and Orphan Diseases" PORTFOLIO NEWS Dec 06, 2018 XyloCor Therapeutics Raises $17 Million in Series A PORTFOLIO NEWS Nov 27, 2018 BioClin Therapeutics Announces Name Change to Rainier Therapeutics PORTFOLIO NEWS Nov 13, 2018 NextCure Completes a $93M Series B Financing PORTFOLIO NEWS Nov 07, 2018 InCarda Completes $42M Oversubscribed Series B Financing PORTFOLIO NEWS Nov 05, 2018 NextCure and Lilly Announce Collaboration to Discover and Develop Novel Immuno-Oncology Medicines PORTFOLIO NEWS Nov 02, 2018 U.S. FDA Approves Coherus Biosciences' UDENYCA™ SOFINNOVA NEWS Oct 29, 2018 Sarah Bhagat Named as One of the "Nine VCs Who Matter, but You Never Read About" SOFINNOVA NEWS Oct 16, 2018 Mike Powell and Jason Pitts Featured in EndPoints Guest Column "The Real Cost of Drug Development" PORTFOLIO NEWS Oct 03, 2018 ObsEva Reports Additional Positive Phase 3 Results IMPLANT 2 Trial Following IVF PORTFOLIO NEWS Sep 28, 2018 ObsEva’s Final Results of Phase 2b EDELWEISS Trial Shows Sustained Efficacy and Safety PORTFOLIO NEWS Sep 26, 2018 Entasis Therapeutics Announces Pricing of Initial Public Offering PORTFOLIO NEWS Sep 25, 2018 Coherus Biosciences Receives European Commission Approval for Udenyca™ PORTFOLIO NEWS Sep 24, 2018 Amarin's REDUCE-IT™ Cardiovascular Outcomes Study of Vascepa® Capsules Met Primary Endpoint PORTFOLIO NEWS Sep 20, 2018 Y-mAbs Therapeutics Announces Pricing of Initial Public Offering PORTFOLIO NEWS Sep 19, 2018 Galera Therapeutics Raises $150M PORTFOLIO NEWS Sep 18, 2018 BioClin Therapeutics Announces New Leadership PORTFOLIO NEWS Sep 13, 2018 Principia Biopharma Announces Pricing of Initial Public Offering PORTFOLIO NEWS Aug 16, 2018 A women’s health startup tried to drum up interest for a much-needed drug. Many men didn’t get it. PORTFOLIO NEWS Aug 07, 2018 Akouos Raises $50M Series A Financing PORTFOLIO NEWS May 24, 2018 Iterum Announces the Pricing of Initial Public Offering PORTFOLIO NEWS May 23, 2018 Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Initial Public Offering PORTFOLIO NEWS May 14, 2018 Entasis Therapeutics Initiates Clinical Studies of the Oral Extended-Spectrum Beta-Lactamase Inhibitor ETX0282 PORTFOLIO NEWS May 07, 2018 BioClin Therapeutics, Inc., Completes $50M Series B Financing with Addition of New Investors PORTFOLIO NEWS Mar 28, 2018 Edge Therapeutics Provides Update following Interim Analysis of Phase 3 NEWTON 2 Study EVENT Jan 30, 2018 Alan Colowick to Speak at JLABS PORTFOLIO NEWS Jan 22, 2018 Medeor Therapeutics Awarded $18.8M From the California Institute for Regenerative Medicine PORTFOLIO NEWS Jan 04, 2018 Audentes Announces Positive Interim Data from First Dose Cohort of ASPIRO PORTFOLIO NEWS Jan 03, 2018 Ascendis Announces Completion of Target Enrollment in Phase 3 Trial of TransCon Growth Hormone PORTFOLIO NEWS Dec 19, 2017 Spark Therapeutics Announces FDA approval of LUXTURNA™ PORTFOLIO NEWS Dec 18, 2017 Aerie Pharmaceuticals Announces U.S. FDA Approval of Rhopressa® PORTFOLIO NEWS Dec 15, 2017 Aclaris Therapeutics Receives FDA Approval for the Treatment of Raised Seborrheic Keratoses PORTFOLIO NEWS Dec 13, 2017 Pionyr Immunotherapeutics Completes $62M Series B Financing PORTFOLIO NEWS Nov 29, 2017 Y-mAbs Announces Closing of $30M Extension of Private Equity Placement PORTFOLIO NEWS Nov 28, 2017 Medeor Therapeutics Raises $57M In Series B Financing PORTFOLIO NEWS Nov 14, 2017 Apellis Announces the Pricing of Initial Public Offering PORTFOLIO NEWS Nov 07, 2017 ObsEva Announces Completion of Patient Recruitment for the Treatment of Endometriosis SOFINNOVA NEWS Oct 24, 2017 Sofinnova Steps Up PORTFOLIO NEWS Sep 27, 2017 NuCana PLC Announces Pricing of Initial Public Offering PORTFOLIO NEWS Sep 05, 2017 Entasis Announces $31.9M Extension of Series B Financing PORTFOLIO NEWS Aug 10, 2017 Apellis Pharmaceuticals Announces $60M Series E Financing PORTFOLIO NEWS Aug 02, 2017 Amplyx Pharmaceuticals Raises $67M in Series C Financing PORTFOLIO NEWS Jun 15, 2017 Art Krieg comes down from the mountain with a $27M round for Checkmate Pharmaceuticals EVENT Jun 09, 2017 Jim Healy to Speak at BIO on Market & Political Pressures EVENT Jun 07, 2017 Mike Powell to be a Judge at BIO's Start-Up Stadium SOFINNOVA NEWS May 30, 2017 Sofinnova Announces the Addition of Industry Leader Alan Colowick, MD, MPH to its Partnership EVENT Apr 11, 2017 Jim Healy to Speak at Cancer Advance Boston PORTFOLIO NEWS Mar 28, 2017 Virtual biotech Antiva sets out on a big R&D quest, armed with a $22M round for an HPV therapy EVENT Feb 06, 2017 Charlotte Shropshire to Speak at SuperReturn US West SOFINNOVA NEWS Oct 17, 2016 Sofinnova Raises $650M Biotech-focused Venture Fund SOFINNOVA NEWS Apr 11, 2016 12 VCs Who Matter, But You Never Read About SOFINNOVA NEWS Jan 12, 2016 Despite 'choppy' markets, fundamentals strong as health care world heads to JPM logo_sofi 3000 Sand Hill Rd Building 4, Suite 250 Menlo Park, CA 94025 (650) 681-8420 1250 Prospect Street, Ocean Level - 4 La Jolla, CA 92037 (858) 551-4880 1000 Rue de la Gauchetière Ouest, Suite 2400 Montreal, Quebec H3B 4W5 © 2021 Sofinnova | Privacy Policy